10 employees
ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases.
2019
$16M
from 1 investors over 1 rounds
ImmuneSensor Therapeutics raised $16M on September 20, 2022
Investors: Cancer Prevention and Research Institute of Texas